Effect of amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients

International Journal of Food Sciences and Nutrition

Volumn 62, Issue 6, 2011, Pages 609-616

  Akhtar, Muhammad Shoaib ^a   Ramzan, Ayesha ^b   Ali, Amanat ^c   Ahmad, Maqsood ^a  

^a UNIVERSITY OF SARGODHA   (Pakistan)

^b UNIVERSITY OF AGRICULTURE   (Pakistan)

^c SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

Amla fruit; blood glucose; Emblica officinalis Gaertn.; lipid profile; normal and diabetic human volunteers

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT MEDICINAL PRODUCT; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; EMBLICA OFFICINALIS; FEMALE; FRUIT; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; REFERENCE VALUE;

ADULT; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; FRUIT; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; LIPIDS; MALE; MIDDLE AGED; PHYLLANTHUS EMBLICA; PLANT PREPARATIONS; POSTPRANDIAL PERIOD; REFERENCE VALUES; TRIGLYCERIDES;

PHYLLANTHUS EMBLICA;

EID: 79961201714     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2011.560565     Document Type: Article

References (50)

1. Akhtar MS. 1982. Trials of Momordica charantia powder in patients with maturity onset diabetes: A preliminary report. J Pak Med Acad 32:106-107. (Pubitemid 12018416)
2. Akhtar MS. 1992. Hypoglycemic activities of some indigenous medicinal plants traditionally used as anti-diabetic drug. J Pak Med Acad 42:271-277. (Pubitemid 23035955)
3. Akhtar MS. 1995. Efficacy of some indigenous medicinal plants in diabetic patients. In: Proceedings of the 2nd Annual National Symposium on Health Care and Social Development. Karachi, Pakistan: The Aga Khan University. p 232-236.
4. Akhtar MS, Ali MR. 1985. Study of hypoglycemic activity of Cuminum nigrum seeds in normal and alloxan-diabetic rabbits. Planta Med 51:81-85. (Pubitemid 15117671)
5. Akhtar MS, Akhtar MA, Yaqub M. 1981. Effect of Momordica charantia on blood glucose level of normal and alloxan diabetic rabbits. Planta Med 42:205-212. (Pubitemid 11007849)
6. Aslokar L, Kakkar KK, Chakre OJ. 1992. Supplement to Glossary of Indian Medicinal Plants with Active Principles. New Delhi, India: Directorate of CSIR. p 291-293.
7. Asmawi MZ, Kankaanranta H, Moilanen R. 1993. Antiinflammatory activities of Emblica officinalis Gaertn leaf extracts. J. Pharm Pharmacol 45:581-584. (Pubitemid 23201446)
8. Broadhurst CL, Polansky MM, Anderson RA. 2000. Insulin like biological activity of culinary and medicinal plant extracts invitro. J Agric Food Chem 48:849-852. (Pubitemid 30194017)
9. Davis SN. 2007. Management of type 2 diabetes mellitus with basal prandial insulin therapy: A case based review. Insulin 2: 118-126. (Pubitemid 47279110)
10. Davis N, Forbes B, Wylie-Rosett J. 2009. Nutritional strategies in type 2 diabetes. Mount Sinai J Med 76:257-268.
11. Freeman JS. 2010. New therapeutic options: Management strategies to optimize glycemic control. J AmOsteopath Assoc 110(3 Suppl 2):515-520.
12. Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 18: 499-502.
13. Garg AN, Kumar A, Nair AG, Reddy AVR. 2005. Determination of minor and trace elements in Trifla-A herbal preparation. J Radioanal Nucl Chem 263:751-758. (Pubitemid 40598015)
14. Grundy SM. 1998. Dietary influence on serum lipids and cholesterol. J lipids Res 31:1149-1172.
15. Hassani-Ranjbar S, Nayebi N, Moradi L, Mehri A, Larijani B, Abdollahi M. 2010. The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia: A systematic review. Curr Pharmac Design 16:2935-2947.
16. Hazra B, Sarkar R, Biswas S, MandalN. 2010. Comparative study of anti-oxidant and reactive oxygen speciesscavenging properties in the extracts of fruits of Terminalia chebula. Terminalia belerica and Emblica officinalis. BMC Complementary Alternative Med 10: 20.
17. He J, Klag MJ, Whelton PK, Mo JP, Chen JY, Qian MC, Mo PS, He GQ. 1995. Oat bran intake selectively lower serum LDL-C concentration of hypercholesterolemic men. Am J Clin Nutr 61: 366-372.
18. Khan A, Safdar M, Khan MMA, Khattak KN, Anderson AR. 2003. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26:3215-3218. (Pubitemid 37466877)
19. Kim HY, Okubo T, Juneja LJ, Yokozawa T. 2010. The protective role of Amla (Emblica officinalis Gaertn) against fructose-induced metabolic syndrome in a rat model. Br J Nutr 103:502-512.
20. Kumar NJ, Loganathan P. 2010. Hypoglycemic effects of Spinacia oleracea in alloxan induced diabetic rats. Global J Biotech Biochem 5:87-91.
21. Laurence DR, Bacharach AL. 1964. Evaluation of Drug Activities: Pharmacometrics. London: Academic Press. p 33-35.
22. Lewis HW, Elvin-Lewis MPH. 1977. Medical Botany: Plant Affecting Man's Health. New York: John Wiley and Sons : 217-218.
23. Lopez-Virella MF. 1977. High density lipoprotein cholesterol estimation. Clin Chem 23:882-884.
24. Lorgeril W. 1999. The medical consequences of high level of triglycerides. Exp Clin Endocrinol Diabetes 106:1-6.
25. Mand JK, Soni GL, Gupta PP, Singh R. 1991. Effect of Amla (Emblica officinalis) on the development of atherosclerosis on hypercholesteromic rabbits. Punjab Agric Univ Ludhiana J Res Edu 10(2):1-7.
26. Mathur R, Sharma A, Dixit VP, Varma M. 1996. Hypolipidemia effect of fruit juice of Embilica officinalis in cholestrol-fed rabbits. J Ethnopharmacol 50(2):61-68. (Pubitemid 26064144)
27. Morelli V, Zoorob RJ. 2000. Alternative therapies Part I. Depression, diabetes, obesity. Ann Farm Physician 62: 1051-1060.
28. Mossihuzzaman M, Nahar N, Ali L. 1994. Hypoglycaemic effects of three plants form Eastern Himalayan belt. Diabetes Res 26(3): 127-138.
29. Mushtaq A, Almas K, Hashmi AS, Hussain SJ, Ahmad I. 2000. Alloxan induced diabetic rabbits. Effects of fibrous and nonfibrous diets on serum glucose and some lipid profile. Prof Med J 7(3):309-312.
30. Muthuraman A, Sood S, Singla SK. 2010. The anti-inflammatory potential of phenolic compounds from Emblica officinalis L. in rats. Inflammopharmacology. Published online on 2nd July 2010. DOI 10.1007/s 10787-010-0041-9.
31. Nampoothiri SV, Prathapan A, Cherian OL, Raghu KG, Venugopalan VV, Sunderasan A. 2010. In-vitro antioxidant and inhibitory potential of Terminalia bellerica and Emblica officinalis fruits against LDL oxidation and key enzymes linked to type 2 diabetes. Food Chem Toxicol 49:125-130.
32. O'Loughlin A, McIntosh C, Dinneen SF, O'Brien T. 2010. Basic concepts to novel therapies: A review of the diabetic foot. Int J Lower Extremity Wounds 9:90-102.
33. Pederson O, Hermenson K, Palmvig B, Pederson SE, Sondergaard K. 1992. Dietary treatment of diabetes recommendations in 1990's. Ugesker Lal ger 154(14):910-916.
34. Perry LM. 1980. Medicinal Plants of East and South-East Asia: Attributed Properties and Uses. Cambridge, MA: MIT Press. p 149-150.
35. Rajagopal K, Sasikala K. 2008. Antihyperglycaemic and antihyperlipidemic effects of Nymphaea stellata in alloxan-induced diabetic rats. Singapore Med J 49(2):137-141. (Pubitemid 351488549)
36. Rajarama-RaoMR, Siddiqui HH. 1964. Pharmacological studies on Emblica officinalis Gaertn. Indian Exp Biol 2:29-31.
37. Reddy VD, Padmavathi P, Kavitha G, Gopi S, Varadacharyulu N. 2010. Emblica officinalis ameliorates alcohol-induced brain mitochondrial dysfunction in rats. J Med Foods 14:62-68.
38. Richmond W. 1973. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19:1350-1356.
39. Robert S. 2002. Diabetes Self-management. New York: R.A. Rappaport Publishing Company.
40. Sabu MC, Kuttan R. 2002. Anti-diabetic activities of medicinal plants and its relationship with their antioxidant properties. J Ethnopharmacol 81:155-160. (Pubitemid 34628497)
41. Said M. 1969. Hamdard Pharmacopoeia of Eastern Medicine. Sadar Karachi, Pakistan: Time Press. p 379.
42. Satyavati GV, Raina MK, Sharma M. 1976. Medicinal Plants of India. Vol. 1. New Delhi: Indian Council of Medical Research. p 48-51.
43. Scartezzini P, Antognoni F, Raggi MA, Poli F, Sabbioni C. 2006. Vitamin C content and antioxidant activity of the fruit and of the Ayurvedic prepration of Emblica officinalis Gaertn. J Ethnopharmacol 104:113-118. (Pubitemid 43234090)
44. Sharma VK, Kumar S, Patel HJ, Hugar S. 2010. Hypoglycemic activity of Ficus glomerata in alloxan-induced diabetic rats. Int J Pharmac Sci Res 1(2):18-22.
45. Sidhu S, Pandhi P, Malhotra S, Vaiphei K, Khanduja KL. 2010. Beneficial effects of Emblica officinalis in L-arginine induced acute pancreatitis in rats. J Med Food 14:147-155.
46. Steel RGD, Torrie JH, Dickey DA. 1997. Principles and Procedures of Statistics. A Biometrical Approach. 3rd ed. New York: McGraw Hill Publishing Company.
47. Vessby B, Karlstron B, Ohroal M, Jarvi A, Anderson A, Basil S. 2000. Diet, nutrition and diabetes mellitus. UPS J Med Sci 105: 151-160.
48. Vinik A. 2007. Advancing therapy in type 2 diabetes mellitus with early comprehensive progression from oral agents to insulin therapy. Clin Ther 29:1236-1253. (Pubitemid 351172224)
49. World Health Organization. 2006. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a World Health Oranization (WHO) and International Diabetes Federation (IDF) Consultation. Geneva, Switzerland: WHO Document Publication Services.
50. Zoeliner N, Kirsch K. 1962. Uber die quantitative Bestimmung von lipiden (mikromethode) mittels der vielen naturlischen lipiden (alle bekannten plasma lipiden) gemeinsamen sulfophosphovanillin reaktion. Z Gesamte Exp Med 135:545-561.